Suzhou Yikesai Biotechnology Co., Ltd
Suzhou Yikesai Biotechnology Co., Ltd., with the mission of "accelerating the application of life sciences and benefiting people's health", is committed to solving the bottleneck of biopharmaceuticals and achieving the localization of key raw materials. It has become one of the excellent enterprises in the upstream core raw materials of biopharmaceuticals in China. The company is a national high-tech enterprise, a national specialized and innovative small giant enterprise, a member of the China International Serum Industry Association (ISIA), and a research center for CD serum-free culture medium engineering in the fields of biopharmaceuticals and cell therapy in Jiangsu Province.
The company currently focuses on three major product segments: serum-free culture media, fetal bovine serum, and identification reagents, providing international quality products and services for customers in biopharmaceuticals, cell and gene therapy, and basic scientific research. The company relies on an international and specialized R&D technology team, quality and production team, and commercialization team to continuously innovate and pursue excellence. While continuously optimizing product performance, it ensures reliable quality and stable supply, fully empowering the rapid and healthy development of the biopharmaceutical industry, and creating cell culture "Chinese chip" products.
Recommended Posts
-
Biyun Tian was founded in 2001 by international students working and studying at Harvard University. For over 20 years, we have been dedicated to independent research and development as well as production. Established in 2007, Shanghai Biyuntian Biotechnology Co., Ltd. is a national level specialized, refined, unique, and new "Little Giant" enterprise. It was further selected as one of the second batch of national level specialized, refined, unique, and new "Little Giant" enterprises recommended for support in the first year. It is also a Shanghai Science and Technology Little Giant Enterprise, a leading enterprise in the G60 Science and Technology Innovation Corridor, one of the top 100 private enterprises driving science and technology innovation in the Yangtze River Delta G60 Science and Technology Innovation Corridor, a "TOP100" brand value list... -
Zhongshan Kangtian Shenghe Biotechnology Co., Ltd. (referred to as "Kangsheng Biotechnology")Overseas ReturneesFounded in April 2018 by Dr. Pan Honghui and several other experts, [2] settled inZhongshan National Health Science and Technology Industry Base——Zhongde (Zhongshan) Biomedical Industry Park is a company that integrates research and development, production, and servicesinternationalizationBiotechnologyThe company. [4] Its core product is applied to proteinsMonoclonal antibodyMedicationsvaccinesDrug development and productionSerum-free culture medium, including chemically restricted culture media, non animal derived culture media [1], and commercially authorizedCHO cellsZhu Development Platform [5]....
-
Under the trend of domestic substitution in the medical device industry, the drive to explore overseas markets is also increasing. Going global is the key for the medical device industry to seek new growth curves and enhance international competitiveness.Moreover, China is implementing a more proactive opening-up strategy. Jointly building the "the Belt and Road" has become a popular international public product and international cooperation platform to achieve higher quality and deeper mutual benefit and win-win results with countries along the line....
